Paresh Dandona

Author PubWeight™ 98.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004 3.17
2 Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003 3.00
3 Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 2004 2.93
4 Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 2009 2.83
5 Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab 2004 2.36
6 Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 2005 2.24
7 Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr 2010 1.85
8 Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 2010 1.61
9 Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care 2010 1.60
10 Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr 2004 1.57
11 Sitagliptin exerts an antinflammatory action. J Clin Endocrinol Metab 2012 1.55
12 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK. Endocr Pract 2015 1.52
13 An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab 2010 1.48
14 Acute modulation of toll-like receptors by insulin. Diabetes Care 2008 1.46
15 Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004 1.46
16 Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care 2007 1.46
17 Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese. J Clin Endocrinol Metab 2007 1.38
18 Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab 2011 1.37
19 Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism 2006 1.36
20 Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 2002 1.35
21 Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin. Endocr Pract 2007 1.35
22 A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab 2011 1.35
23 A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Diabetes Care 2002 1.35
24 Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr 2004 1.23
25 Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 2002 1.19
26 Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care 2006 1.18
27 Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. Metabolism 2004 1.17
28 Liraglutide as additional treatment for type 1 diabetes. Eur J Endocrinol 2011 1.15
29 Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes. J Clin Endocrinol Metab 2003 1.13
30 Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery 2011 1.12
31 Testosterone concentration in young patients with diabetes. Diabetes Care 2008 1.11
32 Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care 2006 1.11
33 Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. J Clin Endocrinol Metab 2006 1.04
34 Suppressive effect of insulin infusion on chemokines and chemokine receptors. Diabetes Care 2010 1.03
35 Durability of effects of exenatide treatment on glycemic control, body weight, systolic blood pressure, C-reactive protein, and triglyceride concentrations. Endocr Pract 2011 1.01
36 Comparative evaluation of adjunctive oral irrigation in diabetics. J Clin Periodontol 2002 1.00
37 Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. J Neurosurg 2011 1.00
38 Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer's disease following gastric bypass surgery. J Clin Endocrinol Metab 2012 0.99
39 A high-carbohydrate diet in the immediate postnatal life of rats induces adaptations predisposing to adult-onset obesity. J Endocrinol 2008 0.98
40 Cardiovascular benefits of exogenous insulin. J Clin Endocrinol Metab 2012 0.95
41 Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler Thromb Vasc Biol 2009 0.95
42 Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 2002 0.95
43 Testosterone concentrations in young pubertal and post-pubertal obese males. Clin Endocrinol (Oxf) 2013 0.94
44 Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes. Diabetes Care 2003 0.93
45 Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus. Endocr Pract 2013 0.93
46 Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes. Diabetes Care 2011 0.93
47 Proinflammatory and prothrombotic effects of hypoglycemia. Diabetes Care 2010 0.91
48 The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients. Diabetes Care 2007 0.91
49 Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions. Curr Drug Targets 2003 0.90
50 Translocation of p47phox and activation of NADPH oxidase in mononuclear cells. Methods Mol Biol 2002 0.89
51 Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism. Atherosclerosis 2012 0.89
52 Antioxidant enzymes induced by repeated intake of excess energy in the form of high-fat, high-carbohydrate meals are not sufficient to block oxidative stress in healthy lean individuals. Br J Nutr 2011 0.87
53 Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood. Atherosclerosis 2013 0.86
54 Maternal obesity and fetal programming: effects of a high-carbohydrate nutritional modification in the immediate postnatal life of female rats. Am J Physiol Endocrinol Metab 2008 0.85
55 Clinical use of liraglutide in type 2 diabetes and its effects on cardiovascular risk factors. Endocr Pract 2012 0.84
56 Free fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation. --to: Steinberg et al. (2002) Vascular function, insulin resistance and fatty acids. Diabetologia 2003 0.84
57 Lipid hydroperoxide-induced tumor necrosis factor (TNF)-alpha, vascular endothelial growth factor and neovascularization in the rabbit cornea: effect of TNF inhibition. Angiogenesis 1998 0.83
58 Lipids, carbohydrates, and heart disease. Metab Syndr Relat Disord 2003 0.82
59 Susceptibility to fatty acid-induced β-cell dysfunction is enhanced in prediabetic diabetes-prone biobreeding rats: a potential link between β-cell lipotoxicity and islet inflammation. Endocrinology 2012 0.82
60 Relationship of prostate-specific antigen to age and testosterone in men with type 2 diabetes mellitus. Endocr Pract 2008 0.81
61 Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial. Metabolism 2004 0.81
62 A novel view of metabolic syndrome. Metab Syndr Relat Disord 2004 0.81
63 Acute myocardial infarction, hyperglycemia, and insulin. J Am Coll Cardiol 2009 0.81
64 Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction. Am J Cardiol 2007 0.80
65 Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus. Diabetes Educ 2005 0.80
66 Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: a common defect? Metab Syndr Relat Disord 2003 0.80
67 Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis. Diabetes Metab Res Rev 2012 0.80
68 Activation of nuclear factor-kappa B (NF-kappa B) in mononuclear cells (MNC). Methods Mol Biol 2002 0.80
69 Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment. J Clin Endocrinol Metab 2005 0.80
70 Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors. Gynecol Oncol 2004 0.80
71 The link between insulin resistance syndrome and inflammatory markers. Endocr Pract 2003 0.78
72 Oestradiol concentrations are not elevated in obesity-associated hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf) 2013 0.77
73 Activation of AP-1 and increased synthesis of MMP-9 in the rabbit retina induced by lipid hydroperoxide. Curr Eye Res 2006 0.77
74 Editorial. Metab Syndr Relat Disord 2003 0.76
75 Insulin infusion and hypoglycemia: clinical implications and prevention. Crit Care Med 2010 0.76
76 Macronutrients, advanced glycation end products, and vascular reactivity. Diabetes Care 2007 0.75
77 Glucose-insulin-potassium for suspected acute myocardial infarction. JAMA 2012 0.75
78 Comment on: Rizzo et al. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012;35:2076-2082. Diabetes Care 2013 0.75
79 Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk: response to wannamethee et Al. Diabetes Care 2010 0.75
80 Glucose-insulin-potassium therapy in patients with STEMI. JAMA 2008 0.75
81 Comment on: Calleja et al. insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke. Diabetes Care 2011;34:2413-2417. Diabetes Care 2012 0.75
82 Insulin therapy and lipid overload in type 2 diabetes. JAMA 2008 0.75
83 Comment on: Lassenius et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011;34:1809-1815. Diabetes Care 2012 0.75
84 Exogenous insulin and hypoglycemia as prognostic factors in critically ill patients. JAMA 2004 0.75
85 Hyperglycemia synergizes endotoxin-induced injury in the heart: reversal with insulin. Crit Care Med 2009 0.75
86 ADJUNCT THERAPIES IN TYPE 1 DIABETES. Endocr Pract 2016 0.75
87 Letter by Chaudhuri et al regarding article, "Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction". Circulation 2010 0.75
88 An inflammatory tale from 3 fatty depots. J Am Coll Cardiol 2011 0.75
89 Comment on: Wehr et al. Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women. Diabetes Care 2011;34:1771-1777. Diabetes Care 2012 0.75
90 Insulin and Alzheimer disease. Arch Neurol 2012 0.75
91 Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome. Metab Syndr Relat Disord 2005 0.75
92 Editorial. Metab Syndr Relat Disord 2003 0.75
93 Editorial. Metab Syndr Relat Disord 2004 0.75
94 Targeting glucose in acute myocardial infarction: has glucose, insulin, and potassium infusion missed the target? Diabetes Care 2007 0.75
95 Glycaemic control and macrovascular complications of type 2 diabetes. Natl Med J India 2009 0.75
96 Brief report: metabolic syndrome and cardiovascular risk factors among the affluent asian indians living in India. Metab Syndr Relat Disord 2004 0.75
97 Editorial. Metab Syndr Relat Disord 2003 0.75
98 In vivo effect of insulin to decrease matrix metalloproteinase-2 and -9 activity after arterial injury. J Vasc Res 2013 0.75
99 Angiotensin II and Inflammation: The Effect of ACE Inhibition and Angiotensin II Receptor Blockade. Metab Syndr Relat Disord 2003 0.75
100 Editorial. Metab Syndr Relat Disord 2003 0.75